Acute Hepatotocixity Following Administration Of Artesunate In Guinea Pigs
The Internet Journal of Toxicology · 2007
DOI: 10.5580/15e2 ↗At a glance
Journal article in The Internet Journal of Toxicology, 2007. Cited 1 times so far (Crossref).
Abstract (original language)
Artesunate is an antimalarial drug commonly employed in chloroquine resistant cases of Plasmodium falciparum infection. The hepatotoxic potentials of artesunate was studied in guineapigs; 0, 2.0, 4.0, 8.0 and 16.0mg/kg were given orally to 4 groups (n = 5) for 7 days. The mean values in body weight of the guinea pigs before and after the drug administration and the serum aspartate aminotransferase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), total bilirubin (TB) and conjugated bilirubin (CB) levels were determined. There was no significant difference (P>0.05) in weight loss or gain of the animals in all dose level at the end of the experiment. The results also showed that there were significant increases of AST only at highest dose (16mg/kg): 21.71 ± 6.9 control(c), 30.81 ± 5.56 text(t) IU/L (P 0.05). The outcome suggests compromise of liver function and possible damage to the hepatocytes at the highest dose level tested.
Cite
APA
(2007). Acute Hepatotocixity Following Administration Of Artesunate In Guinea Pigs. The Internet Journal of Toxicology. https://doi.org/10.5580/15e2
Vancouver
Acute Hepatotocixity Following Administration Of Artesunate In Guinea Pigs. The Internet Journal of Toxicology. 2007. doi:10.5580/15e2
BibTeX
@article{euvimed2007,
title = {Acute Hepatotocixity Following Administration Of Artesunate In Guinea Pigs},
journal = {The Internet Journal of Toxicology},
year = {2007},
doi = {10.5580/15e2}
}
EUVIMED